• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Deadline Approaching: Apply for the Fierce AI Innovation Awards
Mike Doustdar Novo Nordisk Novo Novo CEO
Favicon Fierce Pharma

Novo Nordisk's 'optimistic' CEO Doustdar sits down with Fierce

Novo Nordisk CEO Mike Doustdar told Fierce in an interview that he always believed the Big Pharma “did actually need to become more competitive.”
Fraiser Kansteiner Jun 11, 2026 7:00am
Red heart sewn into white fabric

Kardigan plans to bring in cozy $320M haul from upcoming IPO

Jun 11, 2026 8:14am
FranchiseKeyvisualsOncologyLevel2Digital-nonepng

Could engaging the immune system improve AML outcomes?

Brought to you by Ipsen
head to head against clash football helmets fight combat

Takeda’s TYK2 inhibitor beats BMS’ Sotyktu in psoriasis showdown

Jun 11, 2026 7:00am
London

Fierce Biotech heading to UK amid London Life Sciences Week

Jun 11, 2026 4:57am
caribou herd

Caribou boosts case for off-the-shelf CAR-T v. autologous

Jun 11, 2026 8:00am
More News

Charles River CEO shares ‘the next big transition’ in CRO space

Jun 10, 2026 1:05pm

ADA: Novo CSO says ‘jury still out’ on CagriSema v. retatrutide

Jun 10, 2026 11:10am

GLP-1s may combat depression through a mood-boosting gut microbe

Jun 10, 2026 11:00am

Big Pharma-backed SonoThera sounds off with $125M series B

Jun 10, 2026 10:48am
See more stories
Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings